Find your path to Daniel
434 people in our graph can introduce you to Daniel.
Sign up to see every warm intro you have to Daniel
- Paths you didn't know you had: your email and LinkedIn already hold routes to Daniel. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Biopharma entrepreneur and executive with over 30 years of experience in life sciences strategy and clinical development. He has founded and led companies including Immune Pharmaceuticals and Cytovia Therapeutics and is currently Founder & CEO of NAYA Therapeutics; he leads investment strategy for Yaday Health.
Experience
- NAYA TherapeuticsFounder and CEO, NAYA Therapeuticscurrent2023 — presentMiami, FL
- YADAYManaging Partner, Yaday Healthcurrent2025 — presentMiami, FL
- Miami Biotech CollectiveBoard Membercurrent2025 — present
- CrossjectMember of The Supervisory Board2023 — 2025France
- 21 West Partners/ Kadima Capital VenturesManaging Partner2004 — 2025Miami, Florida, United States
- ImaginosticsExecutive Chairman2024 — 2025Orlando, Florida, United States
- CYTOVIA Therapeutics,IncChairman & CEO2019 — 2023Miami, FL
- Steba Biotech Ltd.Strategic Advisor to Chairman/ CEO2019 — 2020Greater New York City Area
- IMMUNE Pharmaceuticals Inc. (NASDAQ: IMNP)Founder/ Board Director, CEO IMMUNE PHARMA (2011-2017)2011 — 2017Herzliyya, Tel Aviv, Israel and New York, NY
- AccentureManaging Director, Bionest North America2006 — 2009Greater New York City Area
- Syneos HealthChief Global Officer GSW Worldwide2003 — 2004Greater New York City Area
- Monitor DeloitteVice-President & Partner, ISO Healthcare Consulting2001 — 2003Greater New York City Area
- SoftwatchSenior Vice President, Sales, Aliiances and Business Development1999 — 2001Greater New York City Area
- Havas WorldwidePresident, Global Operations, EURO RSCG HEALTHCARE1996 — 1999Paris, France and New York, NY, USA
- WINTEC PharmaChief Executive Officer1993 — 1995
- SanofiChief Operating Officer, Laboratoires Delagrange1991 — 1992Greater Paris Metropolitan Region
- GlaxoSmithKlineVice-President, Marketing & Sales, France1990 — 1991
- NovartisHead, Cardiovascular New Product Development1984 — 1990
Skills & more
Global Business Development11Lifesciences31Venture Capital44Mergers8Management Consulting52Entrepreneur5Biotechnology99Oncology29Vaccines6Commercialization72Start-ups80Corporate Development51
+10 more
Competitive IntelligenceMedical DevicesBusiness DevelopmentBusiness StrategyBusiness PlanningEntrepreneurshipClinical TrialsFDAPharmaceutical IndustryStrategyLanguages English · French · German · Hebrew
From Daniel's professional profile.
Colleagues at Yaday
Frequently asked questions
- Who is Daniel Teper?
- Biopharma entrepreneur and executive with over 30 years of experience in life sciences strategy and clinical development. He has founded and led companies including Immune Pharmaceuticals and Cytovia Therapeutics and is currently Founder & CEO of NAYA Therapeutics; he leads investment strategy for Yaday Health.
- Where does Daniel Teper work?
- Daniel Teper is Managing Partner, Yaday Health at Yaday.
- Where did Daniel Teper go to school?
- Daniel Teper studied at INSEAD (MBA, Business Administration and Management); MIT Sloan School of Management (Certificate, Artificial Intelligence for Pharma and Biotech); The Wharton School (Certificate, Business Administration and Management).
Same school
Also attended INSEAD1,445
Alexandre ProtCo-founder & CEO of QontoSteve AnaviCo-founder & President of QontoPatrick ClaessenPartner at Cottonwood Technology FundChris BischoffInvestment Team at General CatalystJan HammerInvestor at Index VenturesSandra SchwarzerInvestor at Index Ventures
+ 1,439 more
Also attended MIT Sloan School of Management1,030
Doug LeonePartner at Sequoia Capital; former Global Managing PartnerHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsChris MorrisProcess Specialist, Exit Readiness at Mayfair Equity PartnersBirgitteInvestor at InvestinorOla SmebyInvestor at Investinor
+ 1,024 more
Also attended The Wharton School2,000
Sarah GuoFounder & General Partner of ConvictionJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisJack AbrahamFounder, CEO & Managing Partner of AtomicKatie RiesterPartner, Head of Investor Relations at Felicis VenturesRebecca JamesInvestor at Index Ventures
+ 1,994 more
Also attended Université Paris-Saclay44
Arthur MenschCo-founder & CEO of Mistral AILouis DessalSenior Associate at Partech VenturesAlexandra EychenneCompliance & Risk Officer at Partech VenturesAnne-Valérie BachManaging Director at CapagroMelinda JosephVP of Marketing & Investor Relations at InVitro CapitalPierre GaudeauxInvestor at Sanofi Ventures
+ 38 more
Shared employers
Also worked at Miami Biotech Collective3
Also worked at Accenture1,439
Mark SusterManaging Partner at Upfront VenturesChris BrittCo-founder & CEO of ChimeViviana FagaGeneral Partner at Felicis VenturesJulie YangVice President at InvestcorpAmira OujiVice President of Platform & Portfolio Success, Rise of the Rest at RevolutionAntonio GrifoniAssociate at P101 Ventures
+ 1,433 more
Also worked at Syneos Health16
Chris MauneyVice President at NovaQuest Capital Management, L.L.C.David S. WilkesVenture Advisor at Pier 70 VenturesJivesh MadanPrincipal at Shastra VCJohn MaldonadoManaging Partner at Advent InternationalSebastian MettiFounder at Saturn CloudMichael ShiptonChief Business Officer at Lightship
+ 10 more
Also worked at GlaxoSmithKline290
Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Victoria TaylorInvestor at MedicxiErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesJane SuhPrincipal on the AlleyCorp Healthcare teamCarol SuhPartner at ARCH Venture Partners
+ 284 more























































